Amylyx Pharmaceuticals is based in Cambridge, Massachusetts. It has raised $172M in total funding. Latest round: Series C.
Amylyx Pharmaceuticals is based in Cambridge, Massachusetts. Amylyx Pharmaceuticals has raised $172M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in July 2021. The round record for Amylyx Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Viking Global Investors, Belinda Termeer, 683 Capital Management, Bain Capital Life Sciences, Falcon Edge Capital, Marshall Wace and 7 others. 13 distinct backers are named across the disclosed rounds.
Every Amylyx Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026